NasdaqGS - Nasdaq Real Time Price USD
Valneva SE (VALN)
6.81
+0.09
+(1.34%)
At close: April 22 at 4:00:00 PM EDT
6.94
+0.13
+(1.91%)
After hours: April 22 at 4:00:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.2 | -0.19 | -0.73 | -0.73 |
| Low Estimate | -0.21 | -0.19 | -0.75 | -0.78 |
| High Estimate | -0.19 | -0.18 | -0.71 | -0.67 |
| Year Ago EPS | 0.88 | -0.37 | -0.17 | -0.73 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 7 | 9 |
| Avg. Estimate | 40.2M | 44.29M | 193.4M | 259.37M |
| Low Estimate | 36.72M | 41.22M | 184.95M | 220.3M |
| High Estimate | 46.88M | 46M | 207M | 326.26M |
| Year Ago Sales | 32.75M | 38.06M | 169.6M | 193.4M |
| Sales Growth (year/est) | 22.74% | 16.37% | 14.03% | 34.11% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.53 | -0.22 | -0.16 | -0.17 |
| EPS Actual | 0.88 | -0.37 | -0.15 | -0.54 |
| Difference | 0.36 | -0.15 | 0.01 | -0.38 |
| Surprise % | 68.20% | -66.27% | 4.73% | -228.81% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.2 | -0.19 | -0.73 | -0.73 |
| 7 Days Ago | -0.2 | -0.15 | -0.61 | -0.04 |
| 30 Days Ago | -0.2 | -0.15 | -0.61 | -0.04 |
| 60 Days Ago | 0 | 0 | -0.6 | -0.01 |
| 90 Days Ago | 0 | 0 | -0.6 | -0.01 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | -- | 1 | 2 | 2 |
| Down Last 30 Days | -- | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VALN | -122.68% | 49.12% | -321.35% | 0.75% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/15/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Maintains | Guggenheim: Buy to Buy | 3/24/2025 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
13.96
+2.87%
CGEM Cullinan Therapeutics, Inc.
8.37
+3.33%
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%
CGON CG Oncology, Inc.
20.48
+0.34%
DSGN Design Therapeutics, Inc.
3.9600
+10.31%
REPL Replimune Group, Inc.
8.71
-0.63%
IMCR Immunocore Holdings plc
29.52
+0.37%
PHVS Pharvaris N.V.
15.09
+4.07%
ZYME Zymeworks Inc.
12.16
+3.49%
STOK Stoke Therapeutics, Inc.
9.22
+7.08%